FINANCE: XANTHOPOULOS BRINGS LEADERSHIP, FOCUS AND LOCATION TO COMPANIES
Biotech Investor Makes San Diego the Center of His Ecosystem
Originally published May 25, 2016 at 3:55 p.m., updated May 25, 2016 at 3:55 p.m.
Kleanthis Xanthopoulos, a veteran of the San Diego biotech scene, said he expects his latest venture, IRRAS AB, to be profitable by 2018.
San Diego — The growth of San Diego’s biotech hub is often credited to a small but active pool of “serial entrepreneurs...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know